H1N1 Influenza

13 registered clinical trials studyying H1N1 Influenza.

Status	Trial	Sponsor	Phase
Terminated	Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml NCT04810949	Hospital Clinica Nova	N/A
Unknown	Tomographic Findings in COVID-19 and Influenza NCT04497311	Universidad de Guanajuato	—
Completed	Comparison of COVID-19 and H1N1 Influenza Pneumonia NCT04933994	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Completed	H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analys NCT02921997	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome NCT03641690	Centre Hospitalier Universitaire, Amiens	—
Unknown	H1N1 Vaccine Safety in Manitoba, Canada NCT01421251	International Centre for Infectious Diseases, Canada	—
Completed	Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV NCT01002040	University of British Columbia	Phase 4
Terminated	Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial NCT01798602	Canadian Critical Care Trials Group	Phase 2
Unknown	The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A NCT01127282	Seoul National University Hospital	Phase 4
Unknown	Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation NCT01008683	Hadassah Medical Organization	—
Completed	Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal In NCT01011582	Virginia Commonwealth University	—
Terminated	STIP: Statin Trial for Influenza Patients NCT00970606	Gordon Bernard	N/A
Completed	ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS NCT05080933	University of Turin, Italy	—